Results 71 to 80 of about 118,035 (297)

Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi   +19 more
wiley   +1 more source

Reinforcement Learning-based Spectrum Sharing for Cognitive Radio [PDF]

open access: yes, 2011
This thesis investigates how distributed reinforcement learning-based resource assignment algorithms can be used to improve the performance of a cognitive radio system.
Jiang, Tao
core  

Medium usage model for the design of dynamic spectrum management in ISM bands [PDF]

open access: yes, 2012
This paper presents a new approach for dynamic spectrum management for heterogeneous wireless devices. Local congestion degrades the reliability of wireless applications in the License Exempt bands.
Slump, Cornelis H.   +11 more
core   +1 more source

A Comprehensive Exploration of 6G Wireless Communication Technologies

open access: yesComputers
As the telecommunications landscape braces for the post-5G era, this paper embarks on delineating the foundational pillars and pioneering visions that define the trajectory toward 6G wireless communication systems.
Md Nurul Absar Siddiky   +3 more
doaj   +1 more source

Blockchain for Dynamic Spectrum Management [PDF]

open access: yes, 2019
Blockchain is believed to bring new opportunities to dynamic spectrum management (DSM). With features of blockchain, the traditional spectrum management method, such as the spectrum auction, can be improved. It can also help to overcome the challenges about the security or the lack of incentive mechanisms for collaboration in DSM.
openaire   +1 more source

Functional and Structural Evidence of Neurofluid Circuit Aberrations in Huntington Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Disrupted neurofluid regulation may contribute to neurodegeneration in Huntington disease (HD). Because neurofluid pathways influence waste clearance, inflammation, and the distribution of central nervous system (CNS)–delivered therapeutics, understanding their dysfunction is increasingly important as targeted treatments emerge.
Kilian Hett   +8 more
wiley   +1 more source

Normal‐Appearing White Matter Injury Mediates Chronic Deep Venous Hypoxia and Disease Progression in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore how cerebral hypoxia and Normal‐Appearing White Matter (NAWM) integrity affect MS lesion burden and clinical course. Methods Seventy‐nine MS patients, including 13 clinically isolated syndrome (CIS) patients and 66 relapsing–remitting multiple sclerosis (RRMS) patients, and 44 healthy controls (HCs) were recruited from ...
Xinli Wang   +8 more
wiley   +1 more source

Analysis of Radio Spectrum Market Evolution Possibilities [PDF]

open access: yes
A tremendous growth in wireless traffic volumes and a shortage of feasible radio spectrum has led to a situation where the old and rigid spectrum regime is not a viable option for spectrum management and a shift towards a more market driven approach has ...
Thomas CASEY
core  

Spectrum Management Issues in Centralized and Distributed Dynamic Spectrum Access

open access: yes, 2021
Dynamic spectrum access (DSA) is a powerful approach to mitigate the spectrum scarcity problem caused by rapid increase in wireless communication demands. Based on architecture design, DSA systems can be categorized as centralized and distributed.
Lin, Yousi
core  

Clinical Validation of Plasma p‐217tau in Neurological Diseases

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐217tau is a minimally invasive but specific biomarker for diagnosing Alzheimer's disease (AD). However, its disease specificity remains to be clinically evaluated. We validated the reliability of the p‐217tau biomarker in 12 other neurological diseases.
Takeshi Kawarabayashi   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy